216 related articles for article (PubMed ID: 35386649)
1. Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans.
Chabot A; Senti G; Erdmann I; Prinz BM; Wüthrich B; Šošić L; Kündig TM; Johansen P
Front Allergy; 2022; 3():832010. PubMed ID: 35386649
[TBL] [Abstract][Full Text] [Related]
2. Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy.
Chabot A; Lang C; Kündig TM; Schmid-Grendelmeier P; Johansen P
Int Arch Allergy Immunol; 2023; 184(10):985-993. PubMed ID: 37467738
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Safety, Efficacy, and Compliance of Intralymphatic Immunotherapy for Allergic Rhinoconjunctivitis: A Systematic Review and Meta-Analysis.
Wang W; Wang X; Wang H; Wang X
Int Arch Allergy Immunol; 2023; 184(8):754-766. PubMed ID: 37105134
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
[TBL] [Abstract][Full Text] [Related]
5. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
6. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children.
Varga EM; Francis JN; Zach MS; Klunker S; Aberer W; Durham SR
Clin Exp Allergy; 2009 Sep; 39(9):1353-7. PubMed ID: 19538349
[TBL] [Abstract][Full Text] [Related]
7. A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies.
Lee SP; Choi SJ; Joe E; Lee SM; Lee MW; Shim JW; Kim YJ; Kyung SY; Park JW; Jeong SH; Jung JH
Allergy Asthma Immunol Res; 2017 May; 9(3):272-277. PubMed ID: 28293934
[TBL] [Abstract][Full Text] [Related]
8. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human.
Freiberger SN; Zehnder M; Gafvelin G; Grönlund H; Kündig TM; Johansen P
Allergy; 2016 Sep; 71(9):1366-70. PubMed ID: 27253988
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of cervical intralymphatic immunotherapy for house dust mite allergic rhinitis: A pilot study.
Wang K; Zheng R; Chen Y; Yu Q; Zhong H; Xiao P; Wang Y; Tang J
Am J Otolaryngol; 2019; 40(6):102280. PubMed ID: 31519431
[TBL] [Abstract][Full Text] [Related]
10. A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy.
Weinfeld D; Westin U; Hellkvist L; Mellqvist UH; Jacobsson I; Cardell LO
Allergy Asthma Clin Immunol; 2020; 16():31. PubMed ID: 32368217
[TBL] [Abstract][Full Text] [Related]
11. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
12. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ
Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032
[TBL] [Abstract][Full Text] [Related]
13. Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial.
Skaarup SH; Schmid JM; Skjold T; Graumann O; Hoffmann HJ
J Allergy Clin Immunol; 2021 Mar; 147(3):1011-1019. PubMed ID: 32679209
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up.
Adlany YK; Šošić L; Senti G; Lang CCV; Wüthrich B; Kündig TM; Johansen P
J Allergy Clin Immunol Glob; 2023 Feb; 2(1):43-50. PubMed ID: 37780115
[TBL] [Abstract][Full Text] [Related]
15. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
Martínez-Gómez JM; Johansen P; Erdmann I; Senti G; Crameri R; Kündig TM
Int Arch Allergy Immunol; 2009; 150(1):59-65. PubMed ID: 19339803
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Seitz MJ; Aberer W; Bodzenta-Lukaszyk A; Bonifazi F; Campi P; Darsow U; Haeberli G; Hawranek T; Küchenhoff H; Lang R; Quercia O; Reider N; Schmid-Grendelmeier P; Severino M; Sturm GJ; Treudler R; Wüthrich B
PLoS One; 2013; 8(5):e63233. PubMed ID: 23700415
[TBL] [Abstract][Full Text] [Related]
17. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
Hylander T; Larsson O; Petersson-Westin U; Eriksson M; Kumlien Georén S; Winqvist O; Cardell LO
Respir Res; 2016 Jan; 17():10. PubMed ID: 26817454
[TBL] [Abstract][Full Text] [Related]
18. Intralymphatic immunotherapy.
Senti G; Johansen P; Kündig TM
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):537-43. PubMed ID: 19680119
[TBL] [Abstract][Full Text] [Related]
19. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
20. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
